...Stargardt's disease. The company will begin Phase III testing for the product early next year. Makindus... ...reference data on safety and efficacy from the scientific literature or from previously approved products. Makindus... ...FDA approval for Stargardt's, plus single-digit royalties. Makindus declined to disclose a description of MI-100. Makindus Inc....
...Stargardt's disease. The company will begin Phase III testing for the product early next year. Makindus... ...reference data on safety and efficacy from the scientific literature or from previously approved products. Makindus... ...FDA approval for Stargardt's, plus single-digit royalties. Makindus declined to disclose a description of MI-100. Makindus Inc....